HPMC Capsules Sealing with Capsugel CFS1200 Equipment for Small Scale Laboratory Development

Similar documents
Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL

How to Identify Critical Quality Attributes and Critical Process Parameters

Formulation Development

METHOCEL. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

Bioavailability and Bioequivalence Studies

Pharma & Food Solutions. ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications

Computation of Solubility parameters using Molecular. dynamics simulation

LOCTITE 406. Technical Data Sheet. (TDS for new formulation of Loctite 406 ) February-2012

Bringing ideas to life. Full-service pharmaceutical, nutraceutical and cosmetic contract manufacturing

BLISTER PACKING MACHINES AND SERVICES THAT OFFER FLEXIBILITY AND HIGH QUALITY BLISTER PACKS FROM A WIDE VARIETY OF PACKAGING MATERIALS.

Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action

Public Assessment Report. Scientific discussion. Naproxennatrium Banner 220 mg capsules, soft (naproxen sodium) NL/H/2804/001/DC. Date: 28 April 2014

Stability Report. Stability profile of. BIWG 98 SE tablets 40 mg SR of 133. This stability report comprises 133 pages.

Outline CLINICALLY RELEVANT SPECIFICATIONS. ISPE Process Validation Conference September 2017 Bethesda, MD

Public Assessment Report. Scientific discussion. Kruidvat Paracetamol liquid caps 500 mg, soft capsules. (paracetamol) NL License RVG:

Full-Automatic Capsule Filling Machine

Analysis of Non-Pivotal Bioequivalence Studies Submitted in Abbreviated New Drug Submissions for Delayed-Release Drug Products

Review Validation of aseptic processes for pharmaceuticals

Improving Oral Bioavailability by Solid Dispersions: An OSPHENA (Ospemifene) Case Study

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

ANNEX V ASEAN GUIDELINES ON STABILITY STUDY AND SHELF-LIFE OF HEALTH SUPPLEMENTS

GUIDELINE FOR THE STABILITY TESTING

Practical Considerations in Developing High Concentration Antibody Formulations

QIAGEN Supplementary Protocol: Isolation of genomic DNA from tissue using the QIAGEN-tip Storage of tissue samples.

INTERPHEX USA 80-1 ROUTINE EVALUATION OF FILM COATING PROCESSES. M. Talei, Pharm.D., Ph.D. ALZA Corporation Palo Alto, CA INTRODUCTION

DELIVERING SOLUTIONS FOR PATIENTS

White Papers Application of Dominance in Validation

Early Development Best Practices for Stability- Regulatory Perspective

Appendices! Product quality documents. Technical guidelines. (Translation from Original Chinese Version)

International Journal of Pharma and Bio Sciences

PHARMACEUTICAL REFERENCE STANDARDS

This document is valid at the time of distribution. Distributed 10-Apr-2018 (UTC) Introduction

Public Assessment Report. Scientific discussion. Flecazela CR 50 mg, 100 mg, 150 mg and 200 mg, prolonged-release capsules, hard. (flecainide acetate)

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE

QbD (Quality by Design) Has industry benefited from this? WHITE PAPER.

Design and Evaluation of a new Capsule-type Dosage form for Colon-Targeted Delivery of Etoricoxib

Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients

Outline. Opportunities Overview of ASAP Areas of Application ASAP Proposal to Regulators Summary

TABLETABILITY, COMPACTABILITY, AND COMPRESSIBILTY: WHAT S THE DIFFERENCE?

PLGA Nanoparticles. Production and In Situ Drug Loading Using the NanoAssemblr Benchtop Instrument and the Impact of Solvent Removal Methods.

Actavis Italy. Nerviano Plant

Public Assessment Report. Scientific discussion. Pregamid 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg hard capsules.

Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate

Next Generation Structural Acrylic Adhesives. Enhance Productivity and Performance

Roller compactors for the pharmaceutical industry. BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma

Case study 2: Parenteral Drug Product

Your. phar a y. knowledge. isn t complete. without. Complete your digital library with one click at: medicinescomplete.com

ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers

Scientific and Regulatory challenges in Quality by Design (QbD) submissions

Management Team. Over 35 years experience in the pharmaceuticals industry

ICH Q11 Development & manufacture of drug substances

Maxwell RSC Blood DNA Kit

Comments Submitted to the Federal Trade Commission on. the Pfizer-Wyeth and Merck- Schering Plough Mergers

Statistical Evaluation Of Stability Data

Public Assessment Report Scientific discussion. Clindamycin Actavis (clindamycin hydrochloride) SE/H/1538/001-02/DC

Sulfuric acid dilution units

Kollidon SR: A polyvinyl acetate based excipient for DCsustained-release

Validation of a concentration assay using Biacore C

The appropriate solution for every requirement.

Flexible Thermoformable Films

Public Assessment Report Scientific discussion. Celecoxib Pfizer (celecoxib) SE/H/1076/01-02/DC

Roller Compaction: New trends, challenges and solutions

Formulation Development

Partner with the Global Leader in Drug Delivery Systems

Intelligent Disulfide Bond Analysis

Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148

EVALUATION FOR STABILITY DATA

DATWYLER SEALING SOLUTIONS HEALTH CARE

Formulation. Ethoxy-nonafluorobutane + Trans-1, 2-dichlorethylene with Trans-1, 2-dichlorethylene and ethanol

Public Assessment Report. Scientific discussion. Tacrolimus Sandoz 2 mg and 0.75 mg, capsules, hard. (tacrolimus) NL/H/1341/ /DC

GUIDELINES ON THE STABILITY DATA REQUIRED FOR REGISTRATION OF STOCK REMEDIES IN SOUTH AFRICA

HiPer Gel Extraction Teaching Kit (Column Based)

Abstract. Technical Aspects. Applying GastroPlus for Extensions of Biowaivers for BCS Class II Compounds 2

Peptide Mapping: A Quality by Design (QbD) Approach

SCHOTT is an international technology group with more than 125 years of experience in the areas of specialty glasses and materials and advanced

FDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS

Validation of Sterilizing Grade Filters

PHEN 612 SPRING 2008 WEEK 13 LAURENT SIMON

CMC Challenges for cell therapy manufacturing

MG2 and Valpharma: together for the improvement of the production process

Ideally located at the heart of Europe Liège

Purity Determination and DSC Tzero Technology

2.4 TYPES OF MICROBIAL CULTURE

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products

Public Assessment Report. Scientific discussion. Duloxetine Accord 30 mg and 60 mg, gastro-resistant capsules, hard. (duloxetine hydrochloride)

Public Assessment Report. Scientific discussion. Lacidipine Double-e Pharma 2 mg, 4 mg and 6 mg film-coated tablets. (lacidipine)

ISRCTN: EudraCT Number: Sponsor Protocol Number: UCL 08/0350. Pharmacy Manual

Shashank Tiwari et al /J. Pharm. Sci. & Res. Vol.3(10), 2011,

Product Information. Before you begin. Component A 1 vial of 30 ul vial of 300 ul each Glycerol. Tris

DEVICES ARE KEY TO DRUG EFFICACY

Public Assessment Report. Scientific discussion. Linezolid Teva 600 mg, film-coated tablets. (linezolid) NL/H/2945/001/DC

Manufacturing Integrated Biologics Manufacturing

Chlorhexidine for Umbilical Cord Care

Ink Manufacturing and the Dispersion of Pigment into Printing Ink

SUCCESSFUL BRANDS: LATVIA ESTONIA CROATIA GERMANY UNITED KINGDOM BOSNIA-HERZEGOVINA BULGARIA MACEDONIA SERBIA CZECH REPUBLIC SLOVAKIA FRANCE AUSTRIA

Case Study: Merck & Co., Inc.

Formulation and in-vitro evaluation of pregabalin mini tablets for sustained release

International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW

Transcription:

HPMC Capsules Sealing with Capsugel CFS00 Equipment for Small Scale Laboratory Development S. Robin, J. Cuevas, D. Cade Chemical R&D Department, Capsugel France, Division of Pfizer Dominique.Cade@pfizer.com Poster presented at the 009 Annual Meeting and Exposition of the American Association of Pharmaceutical Scientists. Los Angeles, California November 8-, 009 BAS 07

HPMC Capsules Sealing With Capsugel CFS00 Equipment for Small Scale Laboratory Development S. Robin, J. Cuevas, D. Cade Chemical R&D Department, Capsugel France, Division of Pfizer Dominique.Cade@pfizer.com Key words: Hypromellose capsule, encapsulation, sealing, small scale development PURPOSE The work presented hereafter demonstrates that made of hydroxypropylmethyl cellulose (HPMC) can be sealed on Capsugel CFS00 equipment (Photo ) to accelerate early stages of development of new medicines. TM (natural aspect), with good dissolution in demineralized water and Japanese alkaline media, well appreciated in DS market. Vcaps Plus (glossy aspect), with excellent dissolution behavior whatever the dissolution media, designed for pharmaceutical products. Photo : CFS 00 machine HPMC capsule is the non-animal alternative to gelatin capsule, which presents the same machinability, appearance, dissolution profile and better robustness regards to brittleness. As HPMC material equilibrates in standard conditions with lower content of water, it may be an advantage in case of hygroscopic products. Capsugel provides two types of HPMC (Photo ): Photo : empty TM capsule (left) and Vcaps Plus capsule (right) The purpose of this study is to evaluate the consistency of the sealing process of HMPC filled with oily fluid material and sealed on CFS00 equipment. METHODS Product description The natural transparent studied are TM size #0 and Vcaps

Plus size #0. The lecithin solution encapsulated is sunflower lecithin diluted at 0% in sunflower oil to obtain 0cP viscosity at room temperature. The sealing fluid compositions tested here are mixtures of pure alcohol (isopropanol or ethanol) and water 80/0 w/w. inspection. Same sorting is done hours later to confirm all leakers were removed. Encapsulation conditions A design of experiment was performed using three factors at two levels: (L- Vcaps TM /Vcaps Plus), composition (isopropanol/ethanol) and ( C/ C). The eight runs of 00 were repeated to access reproducibility. Each HPMC capsule was filled with 00mg lecithin, closed and sealed in the presence of 0µL on CFS00. After encapsulation, are stored on trays in standard room conditions ( C, 0%RH). Measurement of sealing performances During the sealing trial, are inspected regarding to: Visual quality of the sealed zone (Photo ): are ranked as good (>80% surface covered), medium (>0% surface covered) and poor (risk of leaker because sealing does not cover 60 of the seal zone). Peel test: the cap is cut and peeled off the body after sealing and week after sealing; if peel is easy, score is 0 whereas score equals when peeling is not possible. Leaker rate: are submitted to depression (-0.8bars for 0minutes), then greasy spots are counted and the corresponding are removed for Photo : Filled and sealed TM (left) and Vcaps Plus (right). RESULTS The overall results are consistent between repeats (Fig.). The impact of the factors depends on the response considered. For instance, visual quality and peel test have opposite optimums: - C is better for visual quality, it is worse for peel test. - Ethanol is better for peel test and worse for visual quality. Mean Main Effects Plot for %good visual Data Means 0 0 0 0 0 0 0 0 Plus Ethanol Plus Fig. : Main effects of factors considered in Design of Experiment The detailed results confirm that the optimal conditions depend on the response considered. Capsule type appears important Mean.0..0 0. 0.0.0..0 0. 0.0 Main Effects Plot for peel week Data Means Ethanol

regards to peel test whereas visual quality is relative to composition. TM are ideally sealed with isopropanol at C: visual quality is acceptable and leaker rate is less than % in the presence of fluid product (0cP viscosity at room temperature), whereas seal strength remains poor whatever the conditions. Vcaps Plus can be sealed in the same conditions as TM with equivalent performances. Ethanol is a good option to favor seal strength and to lower the risk of leakers over time as a consequence. included the latest generation of Vcaps Plus designed to favor visual quality and peel test: Vcaps Plus nd generation (Table ). Runs Capsule Acceptable Peel visual Leaker rate Conditions test quality (%) (score) (%) TM C 80 0 0.7 (st generation) 0 C 0 0.9 (ndgeneration) 0 C 70 0.8 (ndgeneration) C 86 0 Table : Confirmation trial of optimal conditions Individual Value Plot of peel week Seal strength is strong at score = and poor at score = 0 peel week 0 Ethanol Fig.: Evolution of visual quality peel week 0 Fig.: Evolution of seal strength Plus Individual Value Plot of peel week Seal strength is strong at score = and poor at score = 0 Ethanol Plus TM and Vcaps Plus demonstrate good behavior on CFS00 sealing machine. The quality of sealed is equivalent or slightly inferior to the quality obtained on large scale sealing equipment LEMS 70. CONCLUSION The Capsugel laboratory sealing machine CFS00 is able to process both types of HPMC manufactured by Capsugel. The quality obtained is suitable for early stages of development of new active molecules (>99% yield). It accelerates the development time by providing rapidly samples ready for pre-clinical batches. We confirmed the optimal conditions for both types at larger scale (,000 instead of 00 per run). We also

REFERENCES E.Cole et al Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into for oral administration, Adv. Drug Del. Review (008) vol.60, 77-76 ACKNOWLEDGEMENT We wish to acknowledge the teams from the Chemical R&D, Colmar plant, Colmar Licaps unit and Dr Keith Hutchison for their support and discussions Poster presented at the 009 Annual Meeting and Exposition of the American Association of Pharmaceutical Scientists. Los Angeles, California November 8-, 009 000600